← Back to All US Stocks

AFJKR Stock Analysis - Aimei Health Technology Co., Ltd. AI Rating

AFJKR Nasdaq Blank Checks CIK: 0001979005
Analysis Date: Mar 19, 2026 | Data as of: 2025-09-30
AI Rating
STRONG SELL
95% Confidence

Investment Thesis

Aimei Health is a blank check company with critical financial distress, including negative stockholders' equity of -$3.4M, virtually no liquid cash ($3K), and severe liquidity crisis with current ratio of 0.01x. The company is burning cash with negative operating cash flow of -$521.9K despite reporting positive net income, signaling accounting quality concerns and unsustainable operations.

AFJKR Strengths

  • + Reported net income of $961.7K in latest period
  • + Total assets of $45.5M provide some asset base
  • + Relatively low total liabilities of $3.5M compared to assets

AFJKR Risks

  • ! Negative stockholders' equity of -$3.4M indicates insolvency
  • ! Critical liquidity crisis with only $3K cash and 0.01x current ratio - immediate solvency risk
  • ! Negative operating cash flow of -$521.9K contradicts positive net income - potential accounting manipulation or non-cash gains
  • ! No revenue reported - business model not operational
  • ! Negative operating income of -$585.2K
  • ! Blank check company status indicates pre-merger/acquisition stage with unproven business model
  • ! Zero insider buying activity signals lack of management confidence

Key Metrics to Watch

AFJKR Financial Metrics

Revenue
N/A
Net Income
$961.7K
EPS (Diluted)
$0.08
Free Cash Flow
$-521.9K
Total Assets
$45.5M
Cash Position
$3.0K

AFJKR Profitability Ratios

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE N/A
ROA 2.1%
FCF Margin N/A

AFJKR Balance Sheet & Liquidity

Current Ratio
0.01x
Quick Ratio
0.01x
Debt/Equity
N/A
Debt/Assets
7.6%
Interest Coverage
N/A
Long-term Debt
N/A

AFJKR 5-Year Financial Trend

AFJKR 5-year financial data:
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Aimei Health Technology Co., Ltd.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $0.08 reflects profitable operations.

AFJKR Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
N/A
Free cash flow / Revenue

AFJKR Capital Allocation

Operating Cash Flow
-$521.9K
Cash generated from operations
Stock Buybacks
$31.3M
Shares repurchased (TTM)
Dividends
None
No dividend program

AFJKR SEC Filings

Access official SEC EDGAR filings for Aimei Health Technology Co., Ltd. (CIK: 0001979005)

Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 19, 2026 | Data as of: 2025-09-30 | Powered by Claude AI